Regeneron Pharmaceuticals Inc (REGN)

Working capital turnover

		Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue (ttm)	US$ in thousands	14,247,800	14,214,200	14,085,700	14,202,000	13,847,100	13,489,100	13,100,100	13,117,200	13,097,300	12,670,800	12,369,900	12,172,900	13,710,200	14,226,800	16,508,100	16,071,700	13,542,900	12,384,100	9,197,600	8,497,100
Total current assets	US$ in thousands	17,980,700	16,859,500	17,571,700	18,660,900	19,333,600	19,081,600	18,871,500	19,479,200	18,634,800	16,923,000	16,909,200	15,884,100	15,428,600	15,529,900	14,306,000	14,014,900	13,775,400	13,337,600	10,055,100	12,753,900
Total current liabilities	US$ in thousands	4,425,100	3,667,000	3,566,600	3,944,300	3,661,000	3,508,600	3,580,900	3,423,400	3,598,600	3,104,400	3,100,100	3,141,300	2,879,200	3,033,900	3,007,600	3,932,500	3,714,800	3,732,400	3,217,800	2,806,800
Working capital turnover		1.05	1.08	1.01	0.97	0.88	0.87	0.86	0.82	0.87	0.92	0.90	0.96	1.09	1.14	1.46	1.59	1.35	1.29	1.35	0.85